Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 350 participants.
Also called NCT07925502
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 350 participants
- Sponsor
- Registry
-
NCT07925502
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07925502. Allocation not applicable; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2030-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit
- Acronym
- aXess4All
- Condition
- End Stage Renal Failure, Hemodialysis
- Intervention (Device)
- Xeltis aXess Hemodialysis Conduit
- Lead sponsor
- Xeltis
Record details
- Record id
cardio:ct-nct07925502- Content hash
a15cbc5d55396379a182ad0a821007e7dcd83a078a6b173fa852c5c6a4d0effe